Diversified Healthcare Trust Closes $120 Million Mortgage Loan

Diversified Healthcare Trust (Nasdaq: DHC) today announced that it closed a $120 million mortgage loan secured by eight properties within DHC’s Medical Office and Life Science Portfolio, located in seven states and consisting of approximately 725,000 square feet. As of March 31, 2024, the weighted average remaining lease term for these properties was 5.4 years and the occupancy rate was 93%. The non-recourse loan has an implied capitalization rate of 7.2% based on the aggregate appraised value for the collateral properties and a loan to value ratio of approximately 50%.

The loan is an interest only 10-year mortgage with a 6.864% all-in fixed interest rate. DHC intends to use approximately 50% of the loan proceeds to redeem a portion of its outstanding 9.750% senior notes due 2025. DHC will use the remainder of the loan proceeds to fund capital investments and improve liquidity.

Matt Brown, Chief Financial Officer and Treasurer of DHC, made the following statement.

“Today’s announced financing is the first step in executing on our broader financing strategy to lower financing costs, improve weighted average remaining debt term and enhance our liquidity profile.”

The lenders were Wells Fargo Bank, National Association, Bank of Montreal and UBS AG.

WARNING CONCERNING FORWARD-LOOKING STATEMENTS

This press release contains statements that constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other securities laws. Also, whenever DHC uses words such as “believe”, “expect”, “anticipate”, “intend”, “plan”, “estimate”, “will”, “may” and negatives or derivatives of these or similar expressions, DHC is making forward-looking statements. These forward-looking statements are based upon DHC’s present intent, beliefs or expectations, but forward-looking statements are not guaranteed to occur and may not occur. DHC currently intends to use approximately 50% of the loan proceeds to redeem a portion of its outstanding 9.75% senior notes due 2025; however, the redemption may not occur or may be delayed. Further, Mr. Brown’s statement regarding DHC’s financing strategy may imply that DHC will be able to sustain and improve its liquidity; however, DHC may not be able to execute on its financing strategies or have sufficient liquidity available to fund its capital needs. Actual results may differ materially from those contained in or implied by DHC’s forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other factors, some of which are beyond DHC’s control.

The information contained in DHC’s filings with the SEC, including under the caption “Risk Factors” in DHC’s periodic reports, or incorporated therein, identifies other important factors that could cause differences from DHC’s forward-looking statements. DHC’s filings with the SEC are available on the SEC’s website at www.sec.gov.

You should not place undue reliance upon forward-looking statements.

Except as required by law, DHC does not intend to update or change any forward-looking statements as a result of new information, future events or otherwise.‎

About Diversified Healthcare Trust:

DHC is a real estate investment trust focused on owning high-quality healthcare properties located throughout the United States. DHC seeks diversification across the health services spectrum by care delivery and practice type, by scientific research disciplines and by property type and location. As of March 31, 2024, DHC’s approximately $7.2 billion portfolio included 371 properties in 36 states and Washington, D.C., occupied by approximately 500 tenants, and totaling approximately 8.5 million square feet of life science and medical office properties and more than 27,000 senior living units. DHC is managed by The RMR Group (Nasdaq: RMR), a leading U.S. alternative asset management company with over $41 billion in assets under management as of March 31, 2024 and more than 35 years of institutional experience in buying, selling, financing and operating commercial real estate. DHC is headquartered in Newton, MA. For more information, visit www.dhcreit.com.

A Maryland Real Estate Investment Trust with transferable shares of beneficial interest listed on the Nasdaq.

No shareholder, Trustee or officer is personally liable for any act or obligation of the Trust.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240530930388/en/